Pangenomic Health Inc. Share Price

Equities

NARA

CA69842E3041

Advanced Medical Equipment & Technology

Delayed Canadian Securities Exchange 14:30:00 03/05/2024 BST 5-day change 1st Jan Change
0.085 CAD 0.00% Intraday chart for Pangenomic Health Inc. +6.25% -57.50%

Financials

Sales 2021 - Sales 2022 - Capitalization 19.99M 27.3M 1.59B
Net income 2021 -2M -2.73M -159M Net income 2022 -12M -16.39M -955M EV / Sales 2021 * -
Net cash position 2021 1.35M 1.84M 107M Net Debt 2022 13.24K 18.09K 1.05M EV / Sales 2022 -
P/E ratio 2021 *
-
P/E ratio 2022
-1.23 x
Employees -
Yield 2021 *
-
Yield 2022
-
Free-Float 91.46%
More Fundamentals * Assessed data
Dynamic Chart
1 day+6.25%
1 week+6.25%
Current month+6.25%
3 months-43.33%
6 months-71.67%
Current year-57.50%
More quotes
1 week
0.08
Extreme 0.08
0.09
1 month
0.08
Extreme 0.08
0.14
Current year
0.05
Extreme 0.05
0.26
1 year
0.05
Extreme 0.05
0.70
3 years
0.05
Extreme 0.05
3.65
5 years
0.05
Extreme 0.05
3.65
10 years
0.05
Extreme 0.05
3.65
More quotes
Managers TitleAgeSince
Chief Executive Officer - 05/09/22
Director of Finance/CFO 50 31/10/21
Chief Operating Officer - -
Members of the board TitleAgeSince
Director/Board Member 57 02-15
Founder 60 10/12/15
Chief Executive Officer - 05/09/22
More insiders
Date Price Change Volume
03/05/24 0.085 +6.25% 8,500
01/05/24 0.08 0.00% 1,910

Delayed Quote Canadian Securities Exchange, May 03, 2024 at 02:30 pm

More quotes
Pangenomic Health Inc. is a precision health company. The Company, through its subsidiaries, is engaged in developing a self-care digital platform to deliver personalized, evidence-based information about natural treatments. Its products include a mobile app for consumers (Nara), a telehealth mental health app and telehealth platform for consumers (Mindleap) and a clinical decision support platform for health practitioners (MUJN). The Nara mobile app provides consumers with a knowledge base, which is based on individual's user profile, leveraging input from mental health questionnaires, drug treatment regimen, genomic sequencing analysis, as well as their protein and microbiome biomarker reports. The Mindleap platform provides a variety of tools and resources to help individuals understand and improve their inner wellness. The MUJN clinical decision support platform provides health practitioners with access to the consumer's mobile app data and their diagnostic reports.
More about the company